# Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency

Study · id `cardio:ct-nct05702970` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05702970](<https://clinicaltrials.gov/study/NCT05702970>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05702970

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 258 participants.

## Technical summary

Registry record NCT05702970. Randomized; single masking; primary purpose treatment. Start 2024-01-15 (anticipated); primary completion 2025-04-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 258 participants (planned count; ClinicalTrials.gov record NCT05702970, source copy `cardio:ctgov-nct05702970-2023-12-15`, retrieved 2026-10-26)
- Planned start: 2024-01-15 (anticipated) (ClinicalTrials.gov record NCT05702970, source copy `cardio:ctgov-nct05702970-2023-12-15`, retrieved 2026-10-26)
- Primary completion: 2025-04-01 (anticipated) (ClinicalTrials.gov record NCT05702970, source copy `cardio:ctgov-nct05702970-2023-12-15`, retrieved 2026-10-26)
- Completion: 2025-10-31 (anticipated) (ClinicalTrials.gov record NCT05702970, source copy `cardio:ctgov-nct05702970-2023-12-15`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05702970-2023-12-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency
- Acronym: VICTORID-HF
- Condition: Heart Failure
- Condition: Iron-deficiency
- Condition: Heart Failure, Systolic
- Condition: Heart Failure NYHA Class II
- Condition: Heart Failure NYHA Class III
- Condition: Vitamin D Deficiency
- Intervention (Drug): Sucrosomial iron
- Intervention (Drug): Vitamin D
- Intervention (Drug): Ferric Carboxymaltose 50 MG/ML
- Lead sponsor: University of Padova
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart failure with reduced ejection fraction (HFrEF) (`cardio:hfref`)
- Registry lists this organization as the lead sponsor: University of Padova (`cardio:org-university-of-padova`)

## Provenance

Content hash: 5ddbd501f0cd63890d66aaad24ce6f17446be86ca03595c76e663343237ea8cb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
